Prof. Ram Subramanian
Scientific Advisory Board
Institution builder, Currently Director of Bindley Bioscience Center, Discovery Park, Purdue University. Former CEO and Co-founder of CCAMP. Founding Dean of inStem, Bangalore.
Deep Science biotech startups have long product life cycles and have to cross several regulatory hurdles. With its inhouse expertise combined with extensive networks, Impres helps the startups clear the hurdle in the most efficient way possible.
Go to market strategy is the most crucial component of any business and much more so for biotech startups. Our ecosystem access includes one of the largest pan India supply chain systems as well as several international partners
Funding is a very important piece in this puzzle and we understand that. Beyond providing seed capital, Impres has an extensive network of family owned offices and global VC funds which can be leveraged for scale.
We work through an iterative process of co-creation with the founders to help them create a scalable, sustainable business model for their company
Technologies developed by deep science biotech startups generally address a global market. With extensive connects in USA, Europe, Japan and Singapore, Impres makes the prospect of addressing a global market a real possibility.
Impres' also acts as a "Launch Pad" for global biotech companies which want to access Indian markets. As a first step, Impres along with its partners is building a physical biotech ecosystem which will act as a "Step up Incubator" for such global companies.
.
Institution builder, Currently Director of Bindley Bioscience Center, Discovery Park, Purdue University. Former CEO and Co-founder of CCAMP. Founding Dean of inStem, Bangalore.
Professor and Chair, Dept. of Molecular Medicine, Morsani College of Medicine, University of South Florida; Sr. Associate Dean of Research and Graduate Education, USF ;
Member, American Association of Advancement of Science (AAAS)
Founder of Evoma, an ecosystem designed for business incubation and for entry of organizations into India. Former chairman of Esco Singapore a systems integration company with operating infrastructure in most Asia Pacific countries including Japan
Managing Director at Paramount Cosmetics India Ltd., a publicly traded company with national presence. Extensive experience in setting up and managing distribution networks.
Serial Entrepreneur, CEO of Bugworks. 28 years experience in industry spanning Semiconductor to Biopharmaceuticals. Founder of Cellworks, Former MD of Spincircuit and Magma India, both of which got acquired by large enterprises.
Dr. Jogin Desai is a doctor-manager, currently Co-founder of Eyestem. Prior to Eyestem, he was part of the global leadership team at Quintiles and headed cardiac safety business. More recently, he was the CEO of Cenduit, the world’s largest standalone randomization company which is a joint venture of Quintiles and ThermoFisher Scientific.
Was awarded the prestigious Prime Minister’s Fellowship to undertake graduate research at inStem, in collaboration with CII and Evolva (a swiss synthetic biology company). 7+ years of training in biochemistry and genomics with 15+ research publications.